This study was conducted to assess the relation between body size and risk of breast cancer among young women. A case-control study was conducted among women aged 21-45 years living in three counties in Washington State. Cases were women born after 1944 with invasive or in situ breast cancer that was diagnosed between January 1, 1983, and April 30, 1990. Controls were selected using random digit dialing and were frequency-matched to cases on the basis of age and county of residence. Interviews took place between 1986 and 1992. Body size was evaluated using indices from several different time periods. After adjustment for confounders, a decreased risk of breast cancer was found for women in the highest quintiie of body mass index (weight (kg)/height (m) 2 ) as compared with the lowest quintiie (for maximum lifetime body mass index, odds ratio = 0.69, 95% confidence interval (Cl) 0.51-0.94). Age modified the relation between body size and risk of breast cancer. The odds ratio for women in the highest quintiie of maximum body mass index who were aged 21-35 years was 0.29 (95% Cl 0.16-0.55), as compared with an odds ratio of 1.5 for women aged 36-45 years (95% Cl 0.9-2.5) (p for interaction = 0.003). This study supports prior research showing a decreased risk of breast cancer associated with increased body size among premenopausal or young women. More detailed analysis in this study found a strong effect that was limited to the youngest age group (£35 years). Am J Epidemiol 1999; 149:339-46.
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The association between obesity and risk of breast cancer is not straightforward. While many studies have found an increased risk of breast cancer in postmenopausal women who are obese (1-3), others have found little or no association (4) . Conversely, several case-control and cohort studies have linked obesity to a decreased risk of breast cancer in young women (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . This seemingly protective effect has been found to reduce the risk of breast cancer by 34 percent (11) to 60 percent (8) among those studies reporting significant results. Other studies, however, did not confirm these findings (15) (16) (17) (18) (19) (20) (21) .
This study was conducted to further investigate the relation between body size and risk of breast cancer among women aged 45 years or younger by assessing body size at several time points in a woman's life. Of particular interest is the possibility that the association might vary by age.
Invasive and in situ cases of breast cancer were identified through the Seattle-Puget Sound branch of the population-based Surveillance, Epidemiology, and End Results (SEER) cancer registry (23) . Cases were restricted to white, English-speaking women born after 1944 who had had primary invasive or in situ breast cancer diagnosed between January 1, 1983, and April 30, 1990 . The study was restricted to women living in the three-county area surrounding Seattle, Washington. Only white women were included, because the racial composition of the population in these three counties is approximately 85 percent white, with no minority group making up more than 5 percent of the population. Of the 1,011 potentially eligible cases identified, 953 (94.3 percent) were living at the time of contact for interview. We did not receive physician approval to contact 37 (3.7 percent) of these cases, and an additional 71 (7.0 percent) cases either refused participation or were lost to follow-up. A total of 845 cases (83.6 percent) were successfully interviewed.
Peacock et a).

Control ascertainment
Control subjects were identified using the Waksberg random digit dialing method with a clustering factor of 2 (24) . A one-stage procedure in which age-eligible women were randomly selected was used to obtain a group with approximately the same age distribution as that of the cases (25) . Eligible controls were white women living in the three study counties who were born after 1944, spoke English, had not developed breast cancer, and had a telephone at their place of residence. King County control subjects were selected for use in both this study and several additional studies. To satisfy the requirements of all of the studies, King County control subjects were frequency-matched to obtain the highest aggregate numbers of controls needed in each age group for these studies. This resulted in loose frequency matching of cases and controls in this study by age (within 5 years) and county of residence.
Several attempts were made to contact potential subjects. Four percent (n = 1,096) of the 27,228 telephone numbers dialed were unanswered after nine attempts. Because prior research has found the majority of such numbers to be nonresidential, these numbers were not included in the response rate calculations (26) . Of the remaining 26,132 telephone numbers, 52.3 percent (n = 13,661) were determined to be nonresidential. Approximately 87 percent (n = 10,817) of the residences contacted did not have an age-eligible woman available for the study or the age-eligible woman was not randomly selected for this study; the occupancy of 3.3 percent (n = 415) of all contacted residences went undetermined. Of the 1,239 eligible women identified, 106 (8.6 percent) refused participation during the screening process, 172 (13.9 percent) refused when contacted for the interview or were lost to follow-up, and 961 (77.6 percent) were successfully interviewed.
Data collection
Each case was assigned a reference date defined as the date of diagnosis of her breast cancer, beyond which exposure information was not collected. Controls were assigned reference dates corresponding to the distribution of the reference dates of cases within each age and county stratum. Cases and controls were interviewed between October 1986 and March 1992. On average, cases were interviewed several months before controls with comparable reference dates. The data collection questionnaire was administered in-person and gathered information on demographic factors, reproductive history, medical history, exercise, and family history of breast cancer, as well as body weight history and height.
Defining body size
Respondents were asked questions about their body size history, including adult height, reference weight, maximum lifetime weight, and weight at age 18. The reference weight was defined as weight 1 year prior to diagnosis for cases and weight on a comparable date for controls. All weight variables were combined with adult height to create a body mass index (BMI) variable, calculated as weight in kilograms divided by height in meters squared. Data on body size variables were categorized into quintiles based on the distribution among the controls. A variable characterizing average annual change in BMI was calculated to examine whether or not an increase in BMI from age 18 to the reference date was associated with risk of breast cancer. This variable was categorized on the basis of whether the change in BMI was negative, remained constant, was slightly positive, or exhibited a large average increase.
Data analysis
Logistic regression was used to estimate the odds ratios for breast cancer associated with each category of body size after adjustment for covariates (27) . Parameter estimates were computed using maximum likelihood estimates. Ninety-five percent confidence intervals were based on the standard error of the coefficient and normal approximation. The following variables were included in the model as potential confounders: age at reference date, annual income, father's educational level, subject's educational level, marital status, age at menarche, menstrual status, parity, age at first full term pregnancy, age at beginning use of oral contraceptives, history of induced abortion (ever/never), breastfeeding, smoking, alcohol use, exercise, family history of breast cancer, and age at which maximum height was attained. A variable was included as a potential confounder in the final model if it changed the odds ratio for the body size variable by at least 5 percent. A separate model was used to assess trends across levels of BMI by testing the statistical significance of a single five-value Linear trend variable (1, 2, etc.) representing categories of exposure.
Tests for effect modification (i.e., the presence of different relations between BMI and breast cancer between groups) included the addition of interaction terms for age, age at menarche, parity, alcohol use, and exercise to the model. The relation between BMI and breast cancer within subgroups of the population (e.g., age groups) was modeled by including interaction terms between BMI (defined categorically) and the subgroup of interest This procedure yielded odds ratio estimates for each category of BMI use within each subgroup. Table 1 presents the characteristics of breast cancer cases and controls. Cases were slightly older than control subjects. Significant increases in risk of breast cancer were found for women who began menstruating by age 12, those who were still menstruating at the reference date, and those who did not have children. No differences were found between cases and controls with regard to lifestyle habits, including smoking, alcohol consumption, and episodes of moderate exercise. Cases with a first degree relative who had been diagnosed with breast cancer had an approximately fourfold increased risk of the disease. There were no differences between cases and controls on measures of socioeconomic status, including education, marital status, and income.
RESULTS
Of the variables analyzed to determine whether they confounded the body size-breast cancer risk relation (see "Materials and Methods"), only age and age at menarche were found to confound the relation. These two variables were controlled for in all further analyses. Table 2 shows age-adjusted and age-and age at menarche-adjusted associations between risk of breast A large annual average increase in BMI from age 18 to the reference date was associated with decreased risk of breast cancer (for an annual average increase in BMI of at least 0.25 versus no change in BMI, odds ratio = 0.70, 95 percent confidence interval 0.54-0.90). This finding remained after adjustment for BMI at age 18, but it decreased somewhat after adjustment for BMI at the reference date (odds ratio = 0.87, 95 percent confidence interval 0.61-1.25).
For further investigation of the relation between body size and breast cancer risk among younger women, data were analyzed to determine whether other factors modified the associations presented. Variables examined for possible effect modification included age, age at menarche, parity, alcohol use, and exercise. Only age at the reference date was found to be an effect modifier (for interactions of BMI at reference date x age and maximum lifetime BMI x age, p = 0.032 and p = 0.003, respectively (table 3)). For women aged 21-35 years, the highest quintile of maximum lifetime BMI was associated with a 70 percent decreased risk versus the lowest quintile of BMI. Among women aged 36-45 years, the pattern was different, with an increasing risk as BMI increased.
DISCUSSION
The general finding of this study that increased body size is inversely associated with risk of breast cancer among young women is consistent with the findings of several previous studies of premenopausal or younger women (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) but contradicts the results of other studies in which no significant relations were found (15) (16) (17) (18) (19) (20) (21) . Because it is not clear what specific aspects of body size might influence its effect on breast cancer risk in young women and because other breast cancer risk factors have been observed to vary in effect by age at exposure, these analyses were conducted with BMI examined at several different time points in a woman's life. The strongest associations were with weight and BMI at the reference date and maximum lifetime BMI, although women in the highest BMI quintile at age 18 were also at reduced risk, which is similar to the findings of London et al. (13) .
Studies of height and risk of breast cancer in young women have produced varied results. Greater height has been found to be associated with an increased risk of breast cancer in some studies (5, 6, 10, 12, 14, 16, 28) , to be a nonsignificant factor in others (11, 13) , and to be related to a possibly decreased risk of breast cancer in at least two (18, 29) . In this study, height was not found to be significantly associated with risk of breast cancer. Although age at which maximum height was attained was related to risk of breast cancer (30), it did not confound the relation between breast cancer risk and BMI.
The unique finding of this study is that age was found to modify the relation between body mass and risk of breast cancer. As is shown in table 3, there was a strong inverse relation between BMI and risk of breast cancer among women aged 21-35 years, but this pattern was not seen in women aged 36-45. Because of the birth year restriction, this study included a greater number of younger women than did other studies. To the authors' knowledge, no prior study of the relation between breast cancer risk and obesity was limited to women under the age of 35.
Key and Pike (31) have put forward an explanation that could clarify the apparently protective effect of obesity on risk for breast cancer in younger women. In their review, Key and Pike suggest that a combination of estrogen plus progesterone induces mitoses of both normal and cancerous breast cells. Obesity in women who are in their childbearing years can create amenorrhea or inconsistent menstrual periods by shortening the luteal phase of the cycle, which is when progesterone is produced and mitosis occurs. This reduction in progesterone decreases the degree of breast cell mitosis, thereby producing a protective effect against breast cancer. This hypothesis has some support in the literature (32, 33) .
Another theory, put forth by Potischman et al. (34) , is that obesity in young women reduces exposure to endogenous estrogens, thereby reducing the risk of breast cancer. Potischman et al. base this theory on a study of 298 subjects aged 20-74 years. In their study, they found that while total estradiol levels increased in postmenopausal women as BMI increased, the opposite was true of premenopausal women (34) . The authors concede, however, that although there have been some small studies confirming their findings (35, 36) , there is not yet a complete consensus (37, 38) , and that more work on the topic of variation in endogenous hormone levels is needed.
This study is one of the few to have examined change in BMI among young women. An average annual increase in BMI of at least 0.25 from age 18 to the reference age was associated with a 30 percent reduction in the risk of breast cancer. This finding is consistent with those of Lubin et al. (39), who also explored the relation between change in weight and risk of breast cancer among young women. Other studies that included women of all ages and did not stratify women according to menopausal status found an increase in weight to be positively associated with the risk of breast cancer, and those investigators have postulated that weight gain acts as a late-stage promoter of breast cancer (3, 40, 41) . All of the associations between body mass indices and breast cancer presented in table 2 became stronger when adjusted for age at menarche. It is well established in the literature that early menarche is associated with an increased risk of breast cancer (42, 43) , and that increased prepubertal body mass is associated with early menarche (44, 45) . It has also been established that obesity in adolescence tends to lead to obesity throughout adult life (46) . The results shown in table 2, unadjusted for menarche, represent the total effect of obesity, including its adverse effect through early menarche. The effect of increased body size becomes more pronounced after adjustment for age at menarche, because the adjusted estimates reflect the decreased risk associated with obesity independent of the adverse effect associated with earlier menarche.
A potential limitation of this study is the possibility of detection bias. Several previous studies have found that smaller tumors were detected more often in thin women as opposed to obese women (10, 11, 13, 47, 48) . It is also possible that many low grade malignant tumors are identified in thinner women which never become apparent in obese women. It is possible that if detection bias is a factor in general, it may be a greater factor in younger women, because they are less likely to be screened for disease unless screening is indicated. However, several studies were able to demonstrate that detection bias, though possibly a factor, did not account for the total discrepancy in breast cancer risk among women with various body sizes (5, 13, 49) .
It is also possible that response bias has influenced the results of this study. We were able to interview only 83.6 percent of all identified cases. Almost 6 percent of the subjects had died by the time their families were contacted. Greenberg et al. (50) found that young women with breast cancer who were obese tended to have poorer prognoses and outcomes. If case women who were obese experienced poorer survival, particularly in the interval soon after diagnosis, it is possible that they would be underrepresented in this analysis. This could have contributed to the decreased risk of cancer seen among women in the higher body mass categories. It is worth noting that three (15) (16) (17) of the seven studies with negative results collected information on weight history either prior to a breast cancer diagnosis or immediately after the diagnosis (in the hospital), which would have reduced this type of bias.
We also were able to interview only 77.6 percent of control subjects. Typically, subjects who participate in a study tend to be in better health than those who do Am J Epidemiol Vol. 149, No. 4, 1999 not, and people in good health tend not to be overweight ("healthy control bias"). Therefore, it is possible that the control subjects underrepresented the percentage of obese women in the population from which they were sampled. This source of bias could have attenuated the observed relation.
Because data collection relied on subject memory for information on many key variables, including weight at different points in time, poor recall may have led to misclassification, including possible differential misclassification. To reduce this problem, study interviewers used several methods to enhance recall, including use of calendars and asking the subject to consider her clothing sizes at different points in her life.
It has also been postulated in previous studies of body size and breast cancer risk among young women that the inverse relation might be influenced by preclinical weight loss associated with the disease. However, this hypothesis has been studied in depth and has generally been discounted (11, 13) . For example, London et al. (13) used the Nurses' Health Study cohort to investigate the incidence of breast cancer associated with body size. They evaluated body size both at the time of completion of the most recent questionnaire (within a 2-year period) prior to diagnosis and 2 years prior to that. They found no substantial differences in the body size-breast cancer risk association between the two dates on which body size was assessed. Additionally, because our study found a consistent inverse relation between risk of breast cancer and body size measured at different time points in a woman's life, it is likely that this bias did not affect the results.
There were no measured factors other than age and age at menarche that confounded the associations between body size and breast cancer risk. A possible limitation of this analysis is the lack of inclusion of dietary variables as confounders. If intake of a particular nutrient played a role in the inverse relation between breast cancer risk and body size, this would suggest that excessive intake of some nutrient both increases body size and decreases breast cancer risk among younger women. Larger body size tends to be associated with greater intake of calories and dietary fat (51, 52) , neither of which has been observed to be associated with a reduced risk of breast cancer (53) (54) (55) .
Because of the large sample size, this study provides some of the strongest evidence yet seen verifying that increased body mass is protective against breast cancer in young women. The additional finding that age is an effect modifier implies that this protective effect is particularly apparent in women aged 35 years and younger. Future research investigating the association between obesity and breast cancer in young women should attempt to account for differences seen in women aged less than 35 years as opposed to women aged 35 or greater.
